Cargando…
A Virtual Screening Platform Identifies Chloroethylagelastatin A as a Potential Ribosomal Inhibitor
Chloroethylagelastatin A (CEAA) is an analogue of agelastatin A (AA), a natural alkaloid derived from a marine sponge. It is under development for therapeutic use against brain tumors as it has excellent central nervous system (CNS) penetration and pre-clinical therapeutic activity against brain tum...
Autores principales: | Caulfield, Thomas R., Hayes, Karen E., Qiu, Yushi, Coban, Mathew, Seok Oh, Joon, Lane, Amy L., Yoshimitsu, Takehiko, Hazlehurst, Lori, Copland, John A., Tun, Han W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599554/ https://www.ncbi.nlm.nih.gov/pubmed/33027969 http://dx.doi.org/10.3390/biom10101407 |
Ejemplares similares
-
Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy
por: von Roemeling, Christina A., et al.
Publicado: (2017) -
Combined alkylation and histone deacetylase inhibition with EDO-S101 has significant therapeutic activity against brain tumors in preclinical models
por: Qiu, Yushi, et al.
Publicado: (2018) -
The ribosome epitranscriptome: inert—or a platform for functional plasticity?
por: Georgeson, Joseph, et al.
Publicado: (2021) -
A scalable platform to discover antimicrobials of ribosomal origin
por: Ayikpoe, Richard S., et al.
Publicado: (2022) -
A virtual research showcase and judging platform created from a patchwork of workplace applications
por: Gawdyda, Lori, et al.
Publicado: (2022)